Zobrazeno 1 - 6
of 6
pro vyhledávání: '"D M, Cappelletty"'
Publikováno v:
Journal of Infectious Disease Pharmacotherapy. 2:57-64
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:691-695
The pharmacodynamics and pharmacokinetics of ceftazidime administered by continuous infusion and intermittent bolus over a 4-day period were compared. We conducted a prospective, randomized, crossover study of 12 critically ill patients with suspecte
Autor:
D M Cappelletty, Michael J. Rybak
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:677-683
The purpose of this study was to determine if synergism was maintained for various combinations of beta-lactams with an aminoglycoside against four clinical strains and one laboratory strain of Pseudomonas aeruginosa which were resistant, according t
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:1797-1801
We compared the pharmacodynamics and killing activity of ceftazidime, administered by continuous infusion and intermittent bolus, against Pseudomonas aeruginosa ATCC 27853 and ceftazidime-resistant P. aeruginosa 27853CR with and without a single dail
Publikováno v:
Antimicrobial agents and chemotherapy. 42(3)
The activities of the oxazolidinone antibacterial agents eperezolid (PNU-100592) and linezolid (PNU-100766) were compared with that of vancomycin against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus (n = 200), coa
Cefepime (CP) is a new injectable cephalosporin with a broad spectrum of activity and stability against common chromosomally and plasmid-mediated beta-lactamases. The bactericidal activities of CP, ceftazidime (CZ), cefotaxime (CTX), and ceftriaxone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9697778156ae1eea6b851d887ce038a2
https://europepmc.org/articles/PMC162823/
https://europepmc.org/articles/PMC162823/